• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Eisai Inc. - Strategic SWOT Analysis Review Product Image

Eisai Inc. - Strategic SWOT Analysis Review

  • Published: September 2013
  • Region: Global
  • 22 pages
  • GlobalData

FEATURED COMPANIES

  • Abraxis BioScience, Inc.
  • Adlyfe Inc.
  • AstraZeneca PLC
  • Ceregene, Inc.
  • MORE

Eisai Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Our summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – READ MORE >

List of Tables
List of Figures
Section 1 - About the Company
Eisai Inc. - Key Facts
Eisai Inc. - Key Employees
Eisai Inc. - Major Products and Services
Eisai Inc. - History
Eisai Inc. - Company Statement
Eisai Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Eisai Inc. - Business Description
Eisai Inc. - SWOT Analysis
SWOT Analysis - Overview
Eisai Inc. - Strengths
Strength - Product Collaboration with Leading Players
Strength - Strong In-house Research Expertise
Strength - Synergy with Parent Company
Eisai Inc. - Weaknesses
Weakness - Litigation Claims
Eisai Inc. - Opportunities
Opportunity - Agreements & Collaborations
Opportunity - Growing Market Opportunities in Emerging Markets
Opportunity - Market Potential – Obesity
Opportunity - Strategic Initiatives
Eisai Inc. - Threats
Threat - Intense Competition
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
Eisai Inc. - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Eisai Inc., Recent Deals Summary
Section 4 – Company’s Recent Developments
Eisai Inc., Recent Developments
Aug 15, 2013: Eisai Launches New Website Providing Employers with Educational Resource for Obesity Management
Mar 05, 2013: DSM Pharma Signs Master Supply Agreement With Eisai
Dec 12, 2012: Biogen Idec And Eisai Announce Manufacturing Alliance At Research Triangle Park Facilities
Jun 26, 2012: GSK, UCB And Eisai Form Joint Working Partnership For Epilepsy Care In NHS Dumfries and Galloway
Jun 22, 2012: Eisai Appoints Shaji Procida As CFO
Section 5 – Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Tables
Eisai Inc., Key Facts
Eisai Inc., Key Employees
Eisai Inc., Major Products and Services
Eisai Inc., History
Eisai Inc., Other Locations
Eisai Inc., Subsidiaries
Eisai Inc., Key Competitors
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Eisai Inc., Recent Deals Summary

List of Figures
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Eisai Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

Abraxis BioScience, Inc.
Salix Pharmaceuticals, Ltd.
AstraZeneca PLC
Koronis Pharmaceuticals, Inc.
Predictive Biosciences, Inc.
Ceregene, Inc.
Adlyfe Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS